KING ABDULLAH MEDICAL CITY
πΈπ¦Saudi Arabia
- Country
- πΈπ¦Saudi Arabia
- Ownership
- -
- Established
- 2010-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
5
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:3
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)β’ Click on a phase to view related trials
Phase 2
3 (75.0%)Not Applicable
1 (25.0%)Polyurethane Foam-Pink Pad (RCT) Use in OR
Not Applicable
Recruiting
- Conditions
- Cardiac Surgery SubjectsPressure Ulcer PreventionPressure Ulcer of SkinPressure Ulcer
- First Posted Date
- 2025-01-24
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- King Abdullah Medical City
- Target Recruit Count
- 100
- Registration Number
- NCT06790277
- Locations
- πΈπ¦
King Abdulla Medical City in Holy capital, Mecca, Western Reagan, Saudi Arabia
A Prospective Randomized Study of General Anesthesia Versus Anesthetist Administered Sedation for ERCP
- Conditions
- Anesthesia
- First Posted Date
- 2019-09-23
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- King Abdullah Medical City
- Target Recruit Count
- 204
- Registration Number
- NCT04099693
- Locations
- πΈπ¦
King Abdullah Medical City, Holy Capital, Mecca, Makkah Western, Saudi Arabia
Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.
Phase 2
Recruiting
- Conditions
- Rectal Cancer
- Interventions
- Drug: Chemotherapy
- First Posted Date
- 2019-05-21
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- King Abdullah Medical City
- Target Recruit Count
- 338
- Registration Number
- NCT03957733
- Locations
- πΈπ¦
King Abdullah Medical City, Holy Capital, Mecca, Makkah Western, Saudi Arabia
Re-challenge Therapy With Chemotherapy & Panitumumab in Metastatic Colorectal Cancer Patients Treated With an Anti-EGFR
- First Posted Date
- 2019-05-07
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- King Abdullah Medical City
- Target Recruit Count
- 30
- Registration Number
- NCT03940131
- Locations
- πΈπ¦
King Abdullah Medical City, Holy Capital, Mecca, Makkah Western, Saudi Arabia
Cholecalciferol Supplementation in Critically Ill Patients With Severe Vitamin D Deficiency.
Phase 2
Terminated
- Conditions
- Critical IllnessVitamin D Deficiency
- Interventions
- Other: Milk (Nestle)
- First Posted Date
- 2016-08-16
- Last Posted Date
- 2020-06-18
- Lead Sponsor
- King Abdullah Medical City
- Target Recruit Count
- 127
- Registration Number
- NCT02868827
- Locations
- πΈπ¦
King Abdullah Medical City, Holy Capital, Mecca, Makkah Western, Saudi Arabia
News
No news found